LNSR | LENSAR, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	7.41 - 7.88
52 Week Range	2.6700 - 8.17
Beta	0.55
Implied Volatility	97.70%
IV Rank	32.21%
Day's Volume	41,047
Average Volume	39,366
Shares Outstanding	11,614,800
Market Cap	89,433,960
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2020-10-02

Valuation
Profitability
Growth
Health
P/E Ratio	-5.27
Forward P/E Ratio	N/A
EPS	-1.46
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	130
Country	USA
Website	LNSR

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.

LNSR's peers: BWAY, ICAD, IINN, IRIX, RXST, AXGN, TMCI, LUNG, OFIX, AZYO, AIMD, SRDX, SSKN, SIEN, SGHT, DYNT, NPCE, MOVE, NMTC, NSPR, NVNO, OWLT, RPID, SRTS, VERO, NXL

*Chart delayed

Analyzing fundamentals for LNSR we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is very weak. For more detailed analysis please see LNSR Fundamentals page.

Watching at LNSR technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on LNSR Technicals page.